Taken together, the studies on BDNF delivery to the entorhinal cortex provide a convincing rationale of ameliorating entorhinal and hippocampal damage, thereby, treating AD symptoms and neuropathology. The gene discussed is BDNF; the disease is Alzheimer disease.